Genetic Variants in Very Sick COVID Patients May Explain Differences in Illness
Findings about the role of structural variants in the host-virus interaction point toward the need to look for genetic variations, ideally via blood assay.
Read MorePosted by Andy Lundin | Feb 3, 2022 | Covid 19 |
Findings about the role of structural variants in the host-virus interaction point toward the need to look for genetic variations, ideally via blood assay.
Read MorePosted by Andy Lundin | Feb 2, 2022 | Disease States |
An international team of scientists found that immune cells called monocytes could be used to predict lung abnormalities and their progression.
Read MorePosted by Andy Lundin | Jan 10, 2022 | Lung Cancer |
A blood test in tandem with reviewing an individual’s smoking history can more accurately determine if they may benefit from lung cancer screening.
Read MorePosted by Andy Lundin | Dec 15, 2021 | Clinical Chemistry, Lung Cancer |
A study shows proof-of-concept of using a drop of blood to reveal lung cancer, which may help diagnose early-stage lung cancer in asymptomatic patients.
Read MorePosted by Andy Lundin | Dec 10, 2021 | Lung Cancer |
Thermo Fisher’s companion diagnostic test to identify targeted therapies for non-small cell lung cancer patients was granted premarket approval by the FDA.
Read More